VYMRUN

What this means for you

Not registered yet, but its 19 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98322364

Mark type

Stylized text

Filed

19 Dec 2023

Attorney of record

Karen Won

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS);; Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD), Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors.

Owner

• Deciphera Pharmaceuticals, LLC, Waltham, MA, US

Prosecution history

• 27 Oct 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
• 26 Apr 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
• 25 Oct 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
• 25 Oct 2024 — LETTER OF SUSPENSION E-MAILED
• 25 Oct 2024 — SUSPENSION LETTER WRITTEN
• 16 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 15 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 15 Oct 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 18 Jul 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 18 Jul 2024 — NON-FINAL ACTION E-MAILED
• 18 Jul 2024 — NON-FINAL ACTION WRITTEN
• 18 Jul 2024 — ASSIGNED TO EXAMINER
• 28 Mar 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 19 Dec 2023 — NEW APPLICATION ENTERED